PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program, which is in Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for treating blinding eye disease named Autosomal Dominant Optic Atrophy, which is in clinical studies; PYC-002, a drug program for the treatment of severe neurodevelopment...
Industry: Biotechnology
Sector: Healthcare
Phone: 61 8 6151 0992
Address:
Harry Perkins Institute of Medical Research, 6 Verdun Street, Nedlands, Australia
